ArticleBMC cancer2026

FGFR pathway inhibition enhances PD-1 blockade and modulates antitumor immunity in colorectal cancer models.

Zhou Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.